nach oben

Erschienen in:

01.06.2019 | Case report

Theophylline

Palpitations and insomnia: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

In a study of 16 patients, two patients [ages and sexes not stated] were described, who developed palpitations or insomnia during treatment with theophylline for syncope without prodromes. Both the patients started receiving oral theophylline 600mg twice daily, which was subsequently titrated to the maximum tolerated dosage. However, one patient discontinued theophylline after 10 months due to palpitations, whereas the second patient discontinued theophylline after 24 months due to insomnia [time to reactions onsets not stated]. Both patients later underwent pacemaker insertion [outcomes not stated]. …

Brignole M, et al. Efficacy of theophylline in patients with syncope without prodromes with normal heart and normal ECG. International Journal of Cardiology 289: 70-73, 15 Aug 2019. Available from: URL: http://doi.org/10.1016/j.ijcard.2019.03.043 - Italy

Titel: Theophylline
Palpitations and insomnia: 2 case reports
Publikationsdatum: 01.06.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-64138-z

Springer Medizin

Theophylline

Palpitations and insomnia: 2 case reports

Excerpt

Weitere Artikel der Ausgabe 1/2019

Cladribine

Prednisone

Panobinostat/programmed cell death-1 receptor antagonists

Health Canada: cancer risk with gentian violet products?

Bedaquiline/delamanid

Denosumab

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Cladribine

Prednisone

Panobinostat/programmed cell death-1 receptor antagonists

Health Canada: cancer risk with gentian violet products?

Bedaquiline/delamanid

Denosumab